KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Cash from Financing Activities (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Cash from Financing Activities data on record, last reported at -$897.0 million in Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 272.82% year-over-year to -$897.0 million; the TTM value through Dec 2025 reached $326.0 million, up 167.29%, while the annual FY2025 figure was $326.0 million, 167.29% up from the prior year.
  • Cash from Financing Activities reached -$897.0 million in Q4 2025 per ZBH's latest filing, down from $483.8 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $575.4 million in Q1 2025 and bottomed at -$897.0 million in Q4 2025.
  • Average Cash from Financing Activities over 5 years is -$150.2 million, with a median of -$170.0 million recorded in 2022.
  • Peak YoY movement for Cash from Financing Activities: plummeted 900.23% in 2021, then soared 1248.5% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$655.8 million in 2021, then surged by 52.21% to -$313.4 million in 2022, then increased by 19.78% to -$251.4 million in 2023, then increased by 4.3% to -$240.6 million in 2024, then plummeted by 272.82% to -$897.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were -$897.0 million in Q4 2025, $483.8 million in Q3 2025, and $163.8 million in Q2 2025.